Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Ablation Technologies Market

  • MAR2978755
  • 230 Pages
  • July 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
The global ablation technologies market was valued at US$ 4.73 Billion in 2017 and is expected to reach US$ 2.82 Billion by 2022 growing at a CAGR of 9.4% during the forecast period 2017-2022. Ablation involves the complete destruction or removal of abnormal tissue with the aim to cure the illness. Ablation technologies based surgeries are negligibly intrusive and are coming up as an alternative to primitive invasive surgical methods. These technologies have applications in various clinical areas such as cancer, cardiac, ophthalmology, urology, gynecology, and orthopedics. The market can be segmented into two categories which are thermal ablation and non-thermal ablation. The thermal ablation technology involves radiofrequency, microwave, ultrasound, hydrothermal, electrical and light or laser technologies whereas, non-thermal ablation category includes cryoablation technology. The main advantage of these procedures over surgery is a short recovery time, low risk of infection, minimum invasion, lesser blood loss, and shorter hospital stays.

Market Dynamics

The major factors driving the growth of this market are rising incidence of cancer and prevalence of cardiovascular diseases. Further adding to the growth prospects of this market are increasing the number of ablation procedures, hospitals, surgical, ablation centers and the emergence of next-generation ablation products and technologies. Apart from these, there has been a significant improvement in the patient quality of life.

On the contrary, the growth of this market is constrained by therapeutic challenges, healthcare cost-containment measures taken in a number of developed countries, lack of properly skilled labor and reprocessing and reuse of devices in developing countries. Even though this procedure lowers the side effects, it has some disadvantages for large and bulky tissues, like bone and neck nodules, which cannot be treated with ablation. Besides, the availability of ablation treatment in remote areas is quite restricted.

Market Segmentation

The market is segmented in terms of the type, application, product, and geography. On the basis of type, it is segmented into laser/light, ultrasound, radiofrequency, electrical, microwave, cryoablation, and hydrothermal ablation technology. By application type, it is segmented into cosmetic surgery, cardiovascular disease treatment, pain management, cancer treatment, ophthalmology, gynecology, urology, orthopedics, among others. On the basis of products, the ablation technologies market is segmented into light/laser ablators, ultrasound ablators, radiofrequency ablators, electrical ablators, microwave ablators, cryoablation devices, and hydrothermal ablators. Geographically, the global ablation technologies market is segmented into North America, Asia-Pacific, Europe, and the Rest of the World. In terms of application, the cardiovascular disease treatment segment is expected to command a major share in 2017. The other important segment is the microwave ablates segment, which is estimated to grow at the highest CAGR during 2017 to 2022.

Regional/Geographic Analysis

The North America region accounts for the largest market share, followed by Europe in 2016. More than 55% of the market is based out of Canada and USA. However, Asia-Pacific is projected to have the highest growth rate during the forecast period owing to the growing focus of global market players, large population base, improving healthcare infrastructure facilities, and the rising prevalence of cancer. The rest of the World market is still at a nascent stage and is expected to grow considering the continuous rise in the prevalence rate of hypertension, cardiovascular and urological diseases.

Opportunities

The market also throws up several opportunities for the need for more advanced and innovative ablation technologies to treat cancer. According to the WHO, the number of new cancer cases is expected to increase by 70% within the next two decades. In addition to this, there is a Shift towards minimal and non-invasive medical procedures and high demand for lasers. The increase in health care spending also adds to the development of this.

Key Players

The market consists of a number of big, medium-sized, and small companies. Some of the major players in the market include Medtronic, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Biosense Webster, Inc. (U.S.), Boston Scientific Corporation (U.S.), AngioDynamics, Inc. (U.S.), CONMED Corporation (U.S.), AtriCure, Inc. (U.S.), Smith & Nephew PLC (U.K.), and Olympus Corporation (Japan).

The report contains comprehensive analysis on:

--> Global paints and coatings Market Segments

--> Global paints and coatings Market Drivers, Restraints and Opportunities

--> Global paints and coatings Market Size & Forecast 2016 to 2022

--> Supply & Demand Value Chain

--> Global paints and coatings Current Trends

--> Competition & Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Feed Software Market includes

Industry Analysis, Forecasts and Opportunity Assessment (2017-2022)

> Market Trends, Dynamics and Regulatory Framework

> Regional and Cross-segment Sales Figures

> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390